Related Experiment Video
Updated: Mar 30, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to
A del Río1, C García-de-la-Mària1, J M Entenza2
1Infectious Diseases Service, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain.
Abstract:
The urgent need of effective therapies for methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) is a cause of concern. We aimed to ascertain the in vitro and in vivo activity of the older antibiotic fosfomycin combined with different beta-lactams against MRSA and glycopeptide-intermediate-resistant S. aureus (GISA) strains. Time-kill tests with 10 isolates showed that fosfomycin plus imipenem (FOF+IPM) was the most active evaluated combination. In an aortic valve IE model with two strains (MRSA-277H and GISA-ATCC 700788), the following intravenous regimens were compared: fosfomycin (2 g every 8 h [q8h]) plus imipenem (1 g q6h) or ceftriaxone (2 g q12h) (FOF+CRO) and vancomycin at a standard dose (VAN-SD) (1 g q12h) and a high dose (VAN-HD) (1 g q6h). Whereas a significant reduction of MRSA-227H load in the vegetations (veg) was observed with FOF+IPM compared with VAN-SD (0 [interquartile range [IQR], 0 to 1] versus 2 [IQR, 0 to 5.1] log CFU/g veg; P = 0.01), no statistical differences were found with VAN-HD. In addition, FOF+IPM sterilized more vegetations than VAN-SD (11/15 [73%] versus 5/16 [31%]; P = 0.02). The GISA-ATCC 700788 load in the vegetations was significantly lower after FOF+IPM or FOF+CRO treatment than with VAN-SD (2 [IQR, 0 to 2] and 0 [IQR, 0 to 2] versus 6.5 [IQR, 2 to 6.9] log CFU/g veg; P < 0.01). The number of sterilized vegetations after treatment with FOF+CRO was higher than after treatment with VAN-SD or VAN-HD (8/15 [53%] versus 4/20 [20%] or 4/20 [20%]; P = 0.03). To assess the effect of FOF+IPM on penicillin binding protein (PBP) synthesis, molecular studies were performed, with results showing that FOF+IPM treatment significantly decreased PBP1, PBP2 (but not PBP2a), and PBP3 synthesis. These results allow clinicians to consider the use of FOF+IPM or FOF+CRO to treat MRSA or GISA IE.
Insights
Fosfomycin combined with imipenem or ceftriaxone shows promise for treating methicillin-resistant Staphylococcus aureus (MRSA) and glycopeptide-intermediate-resistant S. aureus (GISA) infective endocarditis (IE). These combinations were more effective than vancomycin in reducing bacterial load and sterilizing vegetations in animal models.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) and glycopeptide-intermediate-resistant S. aureus (GISA) pose significant therapeutic challenges, particularly in infective endocarditis (IE).
- There is an urgent need for effective treatment options against these resistant strains.
Purpose of the Study:
- To evaluate the in vitro and in vivo efficacy of fosfomycin combined with beta-lactam antibiotics against MRSA and GISA.
- To compare the effectiveness of fosfomycin combinations with vancomycin in a preclinical model of IE.
Main Methods:
- In vitro time-kill tests were conducted using fosfomycin combined with imipenem (FOF+IPM) against 10 MRSA/GISA isolates.
- An aortic valve IE rabbit model was used to compare intravenous regimens: FOF+IPM, fosfomycin plus ceftriaxone (FOF+CRO), standard-dose vancomycin (VAN-SD), and high-dose vancomycin (VAN-HD).
- Bacterial load in vegetations and the number of sterilized vegetations were assessed. Molecular studies investigated the effect on penicillin-binding protein (PBP) synthesis.
Main Results:
- FOF+IPM demonstrated the highest in vitro activity.
- In vivo, FOF+IPM significantly reduced MRSA-277H bacterial load in vegetations compared to VAN-SD and sterilized more vegetations (73% vs. 31%).
- Both FOF+IPM and FOF+CRO significantly reduced GISA-ATCC 700788 load compared to VAN-SD. FOF+CRO sterilized more vegetations (53%) than vancomycin regimens (20%). FOF+IPM treatment decreased PBP1, PBP2, and PBP3 synthesis.
Conclusions:
- Fosfomycin in combination with imipenem or ceftriaxone is a promising therapeutic strategy for MRSA and GISA IE.
- These combinations show superior efficacy over vancomycin in preclinical models, potentially by affecting PBP synthesis.
- Clinicians may consider FOF+IPM or FOF+CRO for treating IE caused by MRSA or GISA.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Endocarditis III: Medical Management
Inhibitors of Bacterial Protein Synthesis

